This paper identifies the risks of contamination by viruses in the manufacture of biopharmaceutical products in cleanrooms. Different types of viruses are described with non-enclosed viruses being more resistant to disinfectants. Care should be taken as many common disinfectants are only suitable for bacterial or fungal contamination. A table gives guidance on the selection of appropriate disinfectant types to deal with viral contamination.
Many types of viruses pose contamination risks to biopharmaceuticals during processing and the majority of these will be located on cleanroom surfaces. Outside of a host cell, viruses cannot replicate. However, they can survive on surfaces as viral particles (virions). Most literature for pharmaceutical manufacturing focuses on disinfectants used to address bacterial or fungal contamination. This article looks at the selection and factors for success relating to disinfectants for the control of viruses.
Sandle, T. (2023) Control of viruses within cleanrooms: A review of disinfectant agents, Clean Air and Containment Review, 49: 18-21
Posted by Dr. Tim Sandle, Pharmaceutical Microbiology Resources (http://www.pharmamicroresources.com/)
No comments:
Post a Comment
Pharmaceutical Microbiology Resources